These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 34013368)
1. An anti‑TROP2 monoclonal antibody TrMab‑6 exerts antitumor activity in breast cancer mouse xenograft models. Tanaka T; Ohishi T; Asano T; Takei J; Nanamiya R; Hosono H; Sano M; Harada H; Kawada M; Kaneko MK; Kato Y Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34013368 [TBL] [Abstract][Full Text] [Related]
2. Development and characterization of TrMab‑6, a novel anti‑TROP2 monoclonal antibody for antigen detection in breast cancer. Sayama Y; Kaneko MK; Kato Y Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300065 [TBL] [Abstract][Full Text] [Related]
3. TrMab-6 Exerts Antitumor Activity in Mouse Xenograft Models of Breast Cancers. Tanaka T; Ohishi T; Saito M; Kawada M; Kaneko MK; Kato Y Monoclon Antib Immunodiagn Immunother; 2022 Feb; 41(1):32-38. PubMed ID: 35225665 [TBL] [Abstract][Full Text] [Related]
4. Anti‑EpCAM monoclonal antibody exerts antitumor activity against oral squamous cell carcinomas. Kaneko MK; Ohishi T; Takei J; Sano M; Nakamura T; Hosono H; Yanaka M; Asano T; Sayama Y; Harada H; Kawada M; Kato Y Oncol Rep; 2020 Dec; 44(6):2517-2526. PubMed ID: 33125138 [TBL] [Abstract][Full Text] [Related]
5. Anti‑HER3 monoclonal antibody exerts antitumor activity in a mouse model of colorectal adenocarcinoma. Asano T; Ohishi T; Takei J; Nakamura T; Nanamiya R; Hosono H; Tanaka T; Sano M; Harada H; Kawada M; Kaneko MK; Kato Y Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34184091 [TBL] [Abstract][Full Text] [Related]
6. Anti‑EGFR monoclonal antibody 134‑mG2a exerts antitumor effects in mouse xenograft models of oral squamous cell carcinoma. Hosono H; Takei J; Ohishi T; Sano M; Asano T; Sayama Y; Nakamura T; Yanaka M; Kawada M; Harada H; Kaneko MK; Kato Y Int J Mol Med; 2020 Oct; 46(4):1443-1452. PubMed ID: 32945346 [TBL] [Abstract][Full Text] [Related]
7. Defucosylated mouse‑dog chimeric anti‑HER2 monoclonal antibody exerts antitumor activities in mouse xenograft models of canine tumors. Suzuki H; Ohishi T; Asano T; Tanaka T; Saito M; Mizuno T; Yoshikawa T; Kawada M; Kaneko MK; Kato Y Oncol Rep; 2022 Sep; 48(3):. PubMed ID: 35856438 [TBL] [Abstract][Full Text] [Related]
8. A defucosylated anti‑CD44 monoclonal antibody 5‑mG2a‑f exerts antitumor effects in mouse xenograft models of oral squamous cell carcinoma. Takei J; Kaneko MK; Ohishi T; Hosono H; Nakamura T; Yanaka M; Sano M; Asano T; Sayama Y; Kawada M; Harada H; Kato Y Oncol Rep; 2020 Nov; 44(5):1949-1960. PubMed ID: 33000243 [TBL] [Abstract][Full Text] [Related]
9. Anti-CD44 Variant 10 Monoclonal Antibody Exerts Antitumor Activity in Mouse Xenograft Models of Oral Squamous Cell Carcinomas. Ishikawa K; Suzuki H; Ohishi T; Li G; Tanaka T; Kawada M; Ohkoshi A; Kaneko MK; Katori Y; Kato Y Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273139 [TBL] [Abstract][Full Text] [Related]
10. Anti-HER2 Cancer-Specific mAb, H Suzuki H; Ohishi T; Tanaka T; Kaneko MK; Kato Y Int J Mol Sci; 2024 Aug; 25(15):. PubMed ID: 39125956 [TBL] [Abstract][Full Text] [Related]
19. Antiglycopeptide Mouse Monoclonal Antibody LpMab-21 Exerts Antitumor Activity Against Human Podoplanin Through Antibody-Dependent Cellular Cytotoxicity and Complement-Dependent Cytotoxicity. Kato Y; Kunita A; Fukayama M; Abe S; Nishioka Y; Uchida H; Tahara H; Yamada S; Yanaka M; Nakamura T; Saidoh N; Yoshida K; Fujii Y; Honma R; Takagi M; Ogasawara S; Murata T; Kaneko MK Monoclon Antib Immunodiagn Immunother; 2017 Feb; 36(1):20-24. PubMed ID: 28234556 [TBL] [Abstract][Full Text] [Related]
20. Nectin-2 is a potential target for antibody therapy of breast and ovarian cancers. Oshima T; Sato S; Kato J; Ito Y; Watanabe T; Tsuji I; Hori A; Kurokawa T; Kokubo T Mol Cancer; 2013 Jun; 12():60. PubMed ID: 23758976 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]